A new study reveals how Staphylococcus aureus bacteria adopt a different diet when colonizing the lungs, suggesting a new treatment strategy for these often dangerous staph infections.
Researchers from the NIH RECOVER Initiative have identified long COVID symptoms in kids and teens, which could ultimately lead to improved diagnoses and treatments for millions.
A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
Columbia scientists have joined a regional consortium to accelerate the development of new drugs that target SARS-CoV-2, other coronaviruses, and viruses that could lead to future pandemics.
In the wake of the COVID pandemic, Anne Moscona is bringing an appreciation for public outreach to her upcoming role as president of the American Society for Virology.
Columbia researchers have uncovered how Gram-negative bacteria—which cause a variety of drug-resistant infections—build their protective outer layer, which could lead to more effective treatments.
On March 28, world leaders and global health experts will gather for Columbia University’s second annual Virtual Symposium on Vaccines and Global Health.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Columbia has helped launch New York City’s new Pandemic Response Institute, which will develop an equitable crisis response that doesn’t leave people behind.